| Literature DB >> 9790190 |
Z Zhang1, H Hartmann, V M Do, D Abramowski, C Sturchler-Pierrat, M Staufenbiel, B Sommer, M van de Wetering, H Clevers, P Saftig, B De Strooper, X He, B A Yankner.
Abstract
Mutations of the presenilin-1 gene are a major cause of familial early-onset Alzheimer's disease. Presenilin-1 can associate with members of the catenin family of signalling proteins, but the significance of this association is unknown. Here we show that presenilin-1 forms a complex with beta-catenin in vivo that increases beta-catenin stability. Pathogenic mutations in the presenilin-1 gene reduce the ability of presenilin-1 to stabilize beta-catenin, and lead to increased degradation of beta-catenin in the brains of transgenic mice. Moreover, beta-catenin levels are markedly reduced in the brains of Alzheimer's disease patients with presenilin-1 mutations. Loss of beta-catenin signalling increases neuronal vulnerability to apoptosis induced by amyloid-beta protein. Thus, mutations in presenilin-1 may increase neuronal apoptosis by altering the stability of beta-catenin, predisposing individuals to early-onset Alzheimer's disease.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9790190 DOI: 10.1038/27208
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962